Kamran Ahmed, MD

Articles

Exciting Developments in the Pipeline in HER2+ MBC

Sara A. Hurvitz, MD;Julia A. LaBarbera, NP;Kamran Ahmed, MD;Erika Rich

March 31st 2022

A multidisciplinary panel of health care professionals and a patient advocate comment on their excitement about novel therapies in the pipeline for HER2-positive metastatic breast cancer.

HER2+ MBC: Radiation Necrosis Vs Disease Progression

Sara A. Hurvitz, MD;Kamran Ahmed, MD

March 31st 2022

Improvements regarding the identification and management of radiation necrosis in patients with HER2-positive metastatic breast cancer.

Radiation and Systemic Therapy for HER2+ Breast Cancer and Brain Metastases

Sara A. Hurvitz, MD;Kamran Ahmed, MD

March 17th 2022

Variables that impact decisions to treat HER2-positive breast cancer and brain metastases with radiation therapy and systemic therapy, and recommendations on using memantine following radiation therapy.

Talking With Patients About HER2+ MBC Treatment Options

Sara A. Hurvitz, MD;Kamran Ahmed, MD

March 3rd 2022

Recommendations for deciding what information is most important to discuss with patients during initial treatment planning for HER2-positive metastatic breast cancer.

Radiation Therapy for HER2+ De Novo MBC

Sara A. Hurvitz, MD;Kamran Ahmed, MD;Erika Rich

February 24th 2022

Radiation oncologist Kamran Ahmed, MD, comments on indications for using radiation therapy to treat patients with HER2-positive de novo metastatic breast cancer.

HER2+ Metastatic Breast Cancer Treatment Advances

Sara A. Hurvitz, MD;Kamran Ahmed, MD;Julia A. LaBarbera, NP;Erika Rich

February 17th 2022

A discussion regarding treatment advances in HER2-positive metastatic breast cancer, a heterogeneous disease.